NexGel, Inc Common Stock (NXGL)

Price$0.64

Favorite Metrics

Price vs S&P 500 (26W)-76.09%

Price vs S&P 500 (4W)-11.85%

Market Capitalization$8.36M

All Metrics

Book Value / Share (Quarterly)$0.55

P/TBV (Annual)4.57x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)77.28%

Cash Flow / Share (Quarterly)$-0.17

Price vs S&P 500 (YTD)-55.69%

Gross Margin (TTM)39.47%

Net Profit Margin (TTM)-26.27%

EPS (TTM)$-0.38

10-Day Avg Trading Volume0.16M

EPS Excl Extra (TTM)$-0.38

Revenue Growth (5Y)76.33%

EPS (Annual)$-0.38

ROI (Annual)-56.03%

Gross Margin (Annual)39.48%

Net Profit Margin (5Y Avg)-130.20%

Cash / Share (Quarterly)$0.04

Revenue Growth QoQ (YoY)-8.06%

ROA (Last FY)-28.68%

Revenue Growth TTM (YoY)31.46%

EBITD / Share (TTM)$-0.30

ROE (5Y Avg)-57.86%

Operating Margin (TTM)-27.93%

Cash Flow / Share (Annual)$-0.17

P/B Ratio1.88x

P/B Ratio (Quarterly)3.87x

Net Income / Employee (Annual)$-0

EV / Revenue (TTM)0.78x

Net Interest Coverage (TTM)-84.09x

ROA (TTM)-28.42%

EPS Incl Extra (Annual)$-0.38

Current Ratio (Annual)1.47x

Quick Ratio (Quarterly)0.59x

3-Month Avg Trading Volume0.21M

52-Week Price Return-72.51%

Revenue / Employee (TTM)$1

Tangible BV / Share (Quarterly)$0.46

P/S Ratio (Annual)0.73x

Asset Turnover (Annual)1.09x

52-Week High$3.02

Operating Margin (5Y Avg)-94.86%

EPS Excl Extra (Annual)$-0.38

CapEx CAGR (5Y)-26.17%

26-Week Price Return-72.10%

Quick Ratio (Annual)0.59x

13-Week Price Return-55.27%

Total Debt / Equity (Annual)0.20x

Current Ratio (Quarterly)1.47x

Enterprise Value$8.94

Revenue / Share Growth (5Y)64.61%

Asset Turnover (TTM)1.08x

Revenue / Employee (Annual)$1

Inventory Turnover (Annual)3.58x

Pretax Margin (Annual)-25.33%

Cash / Share (Annual)$0.04

3-Month Return Std Dev110.68%

Gross Margin (5Y Avg)19.92%

Net Income / Employee (TTM)$-0

ROE (Last FY)-67.28%

Net Interest Coverage (Annual)-50.05x

EPS Basic Excl Extra (Annual)$-0.38

Receivables Turnover (TTM)14.22x

Total Debt / Equity (Quarterly)0.20x

EPS Incl Extra (TTM)$-0.38

Receivables Turnover (Annual)14.22x

ROI (TTM)-51.40%

P/S Ratio (TTM)0.73x

Pretax Margin (5Y Avg)-130.59%

Revenue / Share (Annual)$1.45

Tangible BV / Share (Annual)$0.46

Price vs S&P 500 (52W)-102.34%

Year-to-Date Return-53.04%

5-Day Price Return21.92%

EPS Normalized (Annual)$-0.38

ROA (5Y Avg)-32.30%

Net Profit Margin (Annual)-26.27%

Month-to-Date Return19.43%

Cash Flow / Share (TTM)$-0.45

EBITD / Share (Annual)$-0.27

Operating Margin (Annual)-27.93%

LT Debt / Equity (Annual)0.11x

ROI (5Y Avg)-50.24%

LT Debt / Equity (Quarterly)0.11x

EPS Basic Excl Extra (TTM)$-0.38

P/TBV (Quarterly)4.57x

P/B Ratio (Annual)3.87x

Inventory Turnover (TTM)3.58x

Pretax Margin (TTM)-25.33%

Book Value / Share (Annual)$0.55

Price vs S&P 500 (13W)-55.95%

Beta0.94x

Revenue / Share (TTM)$1.40

ROE (TTM)-61.46%

52-Week Low$0.56

Analyst Recommendations

Jan 2026

Feb 2026

Mar 2026

Apr 2026

4.14

Industry Peers — Surgical & Medical Instruments(108)

Symbol	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
NXGLNexGel, Inc Common Stock	0.73x	76.33%	39.47%	-27.93%	$0.64
SYKStryker Corporation	5.15x	11.84%	64.57%	19.43%	$338.38
BSXBoston Scientific Corp.	4.76x	15.16%	69.01%	18.00%	$63.42
MMM3M Company	3.18x	-4.97%	39.92%	18.55%	$150.55
MDLNMedline Inc. Class A common stock	2.21x	—	26.44%	7.78%	$46.94
BDXBecton, Dickinson and Co.	2.01x	6.32%	46.42%	12.15%	$154.82
RMDResMed Inc.	6.06x	11.72%	60.85%	33.70%	$224.72
DXCMDexCom, Inc.	5.23x	19.33%	62.09%	19.56%	$61.23
WSTWest Pharmaceutical Services, Inc.	6.22x	7.44%	35.91%	19.03%	$269.81
PODDInsulet Corporation	5.31x	24.53%	71.63%	12.92%	$201.47
PENPenumbra, Inc.	9.31x	20.16%	67.14%	13.48%	$331.47

About

NexGel Inc manufactures aqueous polymer hydrogels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics applications. The company differentiates through proprietary manufacturing technologies, including electron beam cross-linking, that enable specialized custom gel development.